These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35908329)

  • 41. Machine learning to predict vasopressin responsiveness in patients with septic shock.
    Scheibner A; Betthauser KD; Bewley AF; Juang P; Lizza B; Micek S; Lyons PG
    Pharmacotherapy; 2022 Jun; 42(6):460-471. PubMed ID: 35426141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Norepinephrine and Vasopressin Discontinuation Order in the Recovery Phase of Septic Shock: A Systematic Review and Individual Patient Data Meta-Analysis.
    Hammond DA; Sacha GL; Bissell BD; Musallam N; Altshuler D; Flannery AH; Lam SW; Bauer SR
    Pharmacotherapy; 2019 May; 39(5):544-552. PubMed ID: 30893494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.
    Bissell BD; Magee C; Moran P; Bastin MLT; Flannery AH
    J Intensive Care Med; 2019 Sep; 34(9):761-765. PubMed ID: 28750598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.
    Hammond DA; Cullen J; Painter JT; McCain K; Clem OA; Brotherton AL; Chopra D; Meena N
    J Intensive Care Med; 2019; 34(11-12):910-916. PubMed ID: 28820036
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of Vasopressin for Vasoplegic Shock in Patients With Preoperative Left Ventricular Dysfunction After Cardiac Surgery: A Propensity-Score Analysis.
    Cheng Y; Pan T; Ge M; Chen T; Ye J; Lu L; Chen C; Zong Q; Ding Y; Wang D
    Shock; 2018 Nov; 50(5):519-524. PubMed ID: 29424795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.
    Morelli A; Ertmer C; Rehberg S; Lange M; Orecchioni A; Cecchini V; Bachetoni A; D'Alessandro M; Van Aken H; Pietropaoli P; Westphal M
    Crit Care; 2009; 13(4):R130. PubMed ID: 19664253
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of vasopressin on acute kidney injury in septic shock.
    Gordon AC; Russell JA; Walley KR; Singer J; Ayers D; Storms MM; Holmes CL; Hébert PC; Cooper DJ; Mehta S; Granton JT; Cook DJ; Presneill JJ
    Intensive Care Med; 2010 Jan; 36(1):83-91. PubMed ID: 19841897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does Switching Norepinephrine to Phenylephrine in Septic Shock Complicated by Atrial Fibrillation With Rapid Ventricular Response Improve Time to Rate Control?
    Haiduc M; Radparvar S; Aitken SL; Altshuler J
    J Intensive Care Med; 2021 Feb; 36(2):191-196. PubMed ID: 31893966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis.
    Barrett LK; Orie NN; Taylor V; Stidwill RP; Clapp LH; Singer M
    Crit Care Med; 2007 Oct; 35(10):2337-43. PubMed ID: 17944022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions.
    Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J
    Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bench-to-bedside review: Vasopressin in the management of septic shock.
    Russell JA
    Crit Care; 2011 Aug; 15(4):226. PubMed ID: 21892977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.
    Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ;
    JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials.
    Nagendran M; Russell JA; Walley KR; Brett SJ; Perkins GD; Hajjar L; Mason AJ; Ashby D; Gordon AC
    Intensive Care Med; 2019 Jun; 45(6):844-855. PubMed ID: 31062052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serious adverse events associated with vasopressin and norepinephrine infusion in septic shock.
    Anantasit N; Boyd JH; Walley KR; Russell JA
    Crit Care Med; 2014 Aug; 42(8):1812-20. PubMed ID: 24919159
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.
    Lupei MI; Beilman GJ; Chipman JG; Mann HJ
    Chirurgia (Bucur); 2009; 104(5):575-81. PubMed ID: 19943557
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Ragoonanan D; Nickelsen P; Tran N; Allen B; Emborski R; Legare A; Villela A; Hampson L; Busey K; Shomo E; Broomfield A; Hailu K
    J Intensive Care Med; 2024 Apr; 39(4):306-312. PubMed ID: 37715634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK.
    Rydz AC; Elefritz JL; Conroy M; Disney KA; Miller CJ; Porter K; Doepker BA
    Shock; 2022 Oct; 58(4):269-274. PubMed ID: 36018257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is the addition of vasopressin to norepinephrine beneficial for the treatment of septic shock?
    Sandifer JP; Jones AE
    Ann Emerg Med; 2013 Nov; 62(5):534-535. PubMed ID: 23683544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.